Gyre Therapeutics, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2017 | 12.2M |
| FY2018 | 23.9M |
| FY2019 | 24.1M |
| FY2020 | 44.2M |
| FY2021 | 61.3M |
| FY2022 | 75.7M |
| FY2023 | 65.8M |
| FY2024 | 102.3M |
| FY2025 | 103.2M |
| FY2026 | 97.0M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2017 | 12.2M |
| FY2018 | 23.9M |
| FY2019 | 24.1M |
| FY2020 | 44.2M |
| FY2021 | 61.3M |
| FY2022 | 75.7M |
| FY2023 | 65.8M |
| FY2024 | 102.3M |
| FY2025 | 103.2M |
| FY2026 | 97.0M |